Skip to main content

Table 2 Characteristics of patients with and without postoperative CHS after combined cerebral revascularization (n, %)

From: Risk factors of postoperative cerebral hyperperfusion syndrome and its relationship with clinical prognosis in adult patients with moyamoya disease

Characteristic

Postoperative CHS

P-value

OR (95% CI)

Absent (n = 148)

Present (n = 12)

Univariate

Multivariate

Age (years old)

40.05 ± 9.34

38.42 ± 11.21

0.567

  

Gender (male)

71 (48%)

6 (50%)

1

  

Clinical type

 

0.537

  

 Ischemic

91 (61.5%)

9 (75%)

   

 Hemorrhagic

57 (38.5%)

3 (25%)

   

Hypertension

55 (37.2%)

5 (41.7%)

0.764

  

Diabetes

21 (14.2%)

0(0%)

0.369

  

Smoking

19 (12.8%)

2 (16.7%)

0.659

  

Mean mRS on admission

1.16 ± 0.61

1.25 ± 0.62

0.609

  

Suzuki stage

  

0.103

  

 Early

21 (14.2%)

0 (0%)

   

 Moderate

78 (52.7%)

10(83.3%)

   

 Advanced

49 (33.1%)

2 (16.7%)

   

Moyamoya vessels

 

0.032a

0.046a

3.04 (1.02–9.03)

 None

26 (17.6%)

1 (8.3%)

   

 Sparse

66 (44.6%)

2 (16.7%)

   

 Dense

56 (37.8%)

9 (75%)

   

Pre-infarction stage

  

0.070

0.368

1.28 (0.75–2.19)

 I

12 (8.1%)

0 (0%)

   

 II

55 (37.2%)

4 (33.3%)

   

 III

65 (43.9%)

4 (33.4%)

   

 IV

16 (10.8%)

4 (33.5%)

   

Operative side (left) 86 (58.1%)

 

11 (91.7%)

0.029a

0.041a

5.16 (1.09–21.34)

Bypass patency

147 (99.3%)

12 (100%)

1

  
  1. CHS cerebral hyperperfusion syndrome, mRS modified Rankin score
  2. aP < 0.05